TCA Cellular Therapy enrolls patients in ALS stem cell trial

TCA Cellular Therapy of Covington, a private stem-cell and research company, has registered the first of six participants for a recently FDA-approved Phase 1 safety trial. The trial will treat ALS patients with their own stem cells.

Click here to read more.

Share this: